Q3 2017 Earnings Show Strong Performance

For highlights from our Q3 2017 earnings report, see the infographic below that details new pharmaceutical products driving our growth, a strategic review of Elanco, and continued progress in our pipeline. For more information and the full readout of results, please view the press release and visit our Investors site.

Q3 2017 Earnings Infographic